Lyn Iemma, aged 75 years at the time of writing, would not describe her life as dramatic. Born and raised in Perth, WA, Australia, this thriving but relaxed city is the place she has always called ...
1d
Pharmaceutical Technology on MSNGalderma enters fierce European atopic dermatitis market with Nemluvio approvalNemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...
7d
GlobalData on MSNSanofi increases ownership stake partaking in pharma buyback trendSanofi has agreed to purchase its own shares worth €2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.
BOS was approved for EoE by the US Food and Drug Administration (FDA ... In terms of biologic treatments, dupilumab is recommended for ages 12 years or older who don’t respond to PPI therapy ...
Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...
These competitive advantages may include greater efficacy in treating a particular disease, less frequent administration ... So, sales of Dupixent (dupilumab), an IL-4/IL-13 inhibitor, in the ...
Just to challenge a little bit of the underlying premise of the question, while we were appropriately rewarded with a broad label, the dupilumab ... The Trump administration has openly stated ...
the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD - as has China's National Medical Products Administration (NMPA), which announced its approval the same day.
That gives it an advantage over other biologics for severe asthma, such as Sanofi/Regeneron's IL-4/IL-13 inhibitor Dupixent (dupilumab ... has attributed to complex administration and a demanding ...
Dupilumab has been approved by the Food and Drug Administration (FDA) for the treatment of adults with PN. In recent years, a subset of patients with PN was reported to experience immune shift ...
After the administration of dupilumab 200 mg eow, in addition to a marked AD improvement the boy was also able to reduce his antihistamine medications and the use of inhaled CS to as-needed basis. He ...
Dupixent (dupilumab) was the first biologic treatment approved for ... Be sure to follow carefully all storage and administration instructions. Biologic treatments are more sensitive than traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results